PSMD1 and COVID-19: Taken together, these data show that SARS-CoV2 S1 and N specific antibodies were readily detectable in high levels that were sustained for up to 70 days in most COVID-19 cases, with nAbs being induced in all clinical categories of COVID-19 patients.